scispace - formally typeset
Open AccessJournal ArticleDOI

Vaccine hesitancy: the next challenge in the fight against COVID-19.

TLDR
It is indicated that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to CO VID-19 vaccination if and when available, and parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy.
Abstract
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

What Lies Behind Substantial Differences in COVID-19 Vaccination Rates Between EU Member States?

TL;DR: Ways to learn the lesson and prevent similar issues in the future are explored, which would require wide-ranging reforms aiming to repair the imperceptible psychological contract between citizens and the state authorities.
Journal ArticleDOI

Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States

Sarah E. Kreps, +1 more
- 30 Mar 2022 - 
TL;DR: Black and Latino respondents were significantly more likely to choose the one-shot viral vector vaccine in the combined efficacy treatment than were whites, and strong preferences for a two-dose mRNA vaccine emerged in treatments where its higher efficacy against symptomatic or severe illness was reported, as well as in the treatment where data on all three efficacy criteria were reported.
Posted ContentDOI

A case-control study of autoimmune AEFIs following COVID-19 vaccination reported to VAERS

Chris von Csefalvay
- 07 Jul 2021 - 
TL;DR: In this paper, a case-control analysis of VAERS reports was conducted to quantify the risk of autoimmune disorders associated with COVID-19 vaccination, and the results showed that the safety profile of COVID19 vaccines with regard to autoimmune AEFIs is highly favorable.
Journal ArticleDOI

Turkish Healthcare Workers’ Personal and Parental Attitudes to COVID-19 Vaccination From a Role Modeling Perspective

Selim Öncel, +2 more
- 01 Feb 2022 - 
TL;DR: The parental COVID-19 vaccine hesitancy of 32% of the healthcare workers is unacceptably high for role modeling against anti-vaccine movement and should be diminished by implementing necessary measures as soon as possible.
References
More filters
Journal ArticleDOI

Covid-19: risk factors for severe disease and death.

TL;DR: A long list is emerging from largely unadjusted analyses, with age near the top of the list of top 10 causes of death in the world of sport.
Journal ArticleDOI

Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases

TL;DR: Although some clinicians have discontinued or have considered discontinuing their provider relationship with patients who refuse vaccines, the American Academy of Pediatrics Committee on Bioethics recommends that clinicians address vaccine refusal by respectfully listening to parental concerns and discussing the risks of nonvaccination.
Journal ArticleDOI

A strategic approach to COVID-19 vaccine R&D.

TL;DR: The ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) public-private partnership brings together the strengths of all sectors at this time of global urgency and a collaborative platform for conducting harmonized, randomized controlled vaccine efficacy trials is discussed.
Related Papers (5)
Trending Questions (1)
What a strong reaction to Covid vaccine may signal?

Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy.